(1) The CHO may, by written notice published on the Agency's website, authorise a person or class of persons to access, use and disclose information held in the monitored medicines database for the following purposes:
(a) the access, use and disclosure would assist in achieving the purposes of:
(i) promoting safe supply, prescription and dispensing practices; and
(ii) reducing harm from monitored medicines;
(b) the access, use and disclosure is for technical or administrative purposes relating to the maintenance of the database;
(c) the access, use and disclosure is to facilitate evaluation and research into monitored medicines and the operation of the monitored medicines database.
(2) Before giving an authorisation under subsection (1), the CHO must be satisfied that the person or class of persons has appropriate arrangements for:
(a) the security of the information; and
(b) when the person or class of persons no longer requires the information – the destruction or disposal of the information.
(3) An authorisation given under subsection (1) may be subject to any conditions the CHO considers appropriate.
(4) The CHO may revoke an authorisation given under subsection (1) at any time.
Note for section 243G
A person's access, use or disclosure of the information may be subject to guidelines made under section 243Q.